Wikidata

(Q82892839)

English

Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer

scientific article published on 01 April 2006

In more languages

Statements

title
Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16549997
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16549997%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q82892839&oldid=1577703795"